Literature DB >> 1884095

Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.

M Hirafuji1, H Shinoda.   

Abstract

1. Platelet-activating factor (PAF, 10 nM) did not induce platelet adhesion to endothelial cells cultured in monolayer but it induced their adhesion to protein-coated plastic. However, PAF induced a marked platelet adhesion to endothelial cells when polymorphonuclear leukocytes (PMNs) were present. Lyso-PAF had no effect. 2. Phase-contrast microscopic examination showed that single platelets rather than their aggregates adhered to the endothelial cell surface around aggregating and adhering PMNs. 3. Significant platelet adhesion was induced by PAF at concentrations higher that 0.01 nM with the maximal response at 10 nM. Platelet adhesion occurred within minutes after PAF addition, reaching a maximum approximately after 30 min. Platelet adhesion also occurred significantly at a PMN:platelet ratio of 1:800, and linearly up to 1:50. 4. The PAF-induced platelet adhesion was suppressed by three structurally unrelated PAF antagonists, WEB 2086, ONO 6240 and BN 52021, in a concentration-dependent manner. 5. PAF also increased PMN adhesion to endothelial cell monolayers, which was further augmented by the presence of platelets. 6. The present study demonstrates that PAF induces platelet adhesion to endothelial cells in vitro when PMNs are present and that there is a close interaction between platelets and PMNs in their adhesion to endothelial cells. The present study further suggests that PMNs could play a central role in platelet adhesion to vascular endothlium in certain pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884095      PMCID: PMC1908373          DOI: 10.1111/j.1476-5381.1991.tb09789.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Leukocyte-platelet interaction. Release of hydrogen peroxide by granulocytes as a modulator of platelet reactions.

Authors:  P H Levine; R S Weinger; J Simon; K L Scoon; N I Krinsky
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

2.  Measurement of in vivo platelet turnover and organ distribution using 111In-labeled platelets.

Authors:  W A Heaton; A D Heyns; J H Joist
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

Review 3.  Consequences of leukocyte-vessel wall interactions in inflammatory and immune reactions.

Authors:  J M Harlan
Journal:  Semin Thromb Hemost       Date:  1987-10       Impact factor: 4.180

4.  Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils.

Authors:  E Coëffier; D Joseph; M C Prévost; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

5.  Superoxide anions enhance platelet adhesion and aggregation.

Authors:  D Salvemini; G de Nucci; J M Sneddon; J R Vane
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

6.  IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.

Authors:  F Breviario; F Bertocchi; E Dejana; F Bussolino
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

7.  A standardized 'in vivo' model for the study of experimental arterial thrombosis: description of a method.

Authors:  R H Bourgain; H Vermariën; R Andries; F Vereecke; J Jacqueloot; J Rennies; E Blockeel; F Six
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

8.  Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.

Authors:  J Casals-Stenzel; G Muacevic; K H Weber
Journal:  J Pharmacol Exp Ther       Date:  1987-06       Impact factor: 4.030

9.  Polymorphonuclear leukocyte-platelet interactions: acetylglyceryl ether phosphocholine-induced platelet activation under stimulation with chemotactic peptide.

Authors:  M Oda; K Satouchi; K Yasunaga; K Saito
Journal:  J Biochem       Date:  1986-11       Impact factor: 3.387

10.  Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin).

Authors:  M Chignard; M A Selak; J B Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  4 in total

1.  Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.

Authors:  R A Hilger; M Köller; W König
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

2.  Dynamic blood cell contact with biomaterials: validation of a flow chamber system according to international standards.

Authors:  M Otto; C L Klein; H Köhler; M Wagner; O Röhrig; C J Kirkpatrick
Journal:  J Mater Sci Mater Med       Date:  1997-03       Impact factor: 3.896

3.  Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.

Authors:  P P McDonald; S R McColl; P Braquet; P Borgeat
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

4.  Nuclear localization of platelet-activating factor receptor controls retinal neovascularization.

Authors:  Vikrant K Bhosle; José Carlos Rivera; Tianwei Ellen Zhou; Samy Omri; Melanie Sanchez; David Hamel; Tang Zhu; Raphael Rouget; Areej Al Rabea; Xin Hou; Isabelle Lahaie; Alfredo Ribeiro-da-Silva; Sylvain Chemtob
Journal:  Cell Discov       Date:  2016-07-12       Impact factor: 10.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.